Tito’s Handmade Vodka "brinda con"...I+D en vacunas COVID19

 

As life changes every day, Tito’s Handmade Vodka continues to support nonprofit organizations, essential workers, and the neighborhoods and communities who have played an important role in our story. We’re doing everything we can to help the folks taking care of us, serving us, and making a difference.

Baylor College of Medicine’s fight against COVID-19 has received a boost from Tito’s Handmade Vodka through a $1 million grant from the brand’s philanthropic arm Love, Tito’s to accelerate research on a vaccine for the virus.

Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor, and Dr. Maria Elena Bottazzi, associate dean of the National School of Tropical Medicine, serve as co-directors of the Texas Children’s Hospital for Vaccine Development, where they develop vaccines for neglected and emerging tropical diseases that impact those living in poverty across the globe.

Now, their team is drawing from the work they started in 2011 to develop a SARS vaccine, with the goal of repurposing it and accelerating a vaccine to protect against SARS-CoV-2, the virus that causes COVID-19. This rapid-switch strategy will rely on the robust and critical scientific information they already compiled during the development of the SARS vaccine and prior work, allowing for significant time-saving and acceleration of a safe and effective COVID-19 vaccine.

“Everything we do at Tito’s is rooted in giving back to the communities we serve, and this pandemic is no exception,” said Dr. Sarah Everett, director of Global Impact and Research at Tito’s Handmade Vodka. “There are dozens of potential vaccines currently in development by scientists across the globe. We applaud the worldwide effort to fund and support vaccines that look promising, because we can never know in advance which ones will be effective. We’re proud to support Dr. Hotez, Dr. Bottazzi and their team’s work to improve humanity’s odds of success against COVID-19 and future coronavirus mutations.”

“It’s an honor to work with Tito’s on this life-saving initiative, which we hope will ultimately lead to a vaccine for America,” Hotez said. “Our vision is that it would also advance as a low-cost global health vaccine, now that COVID-19 is racing through Latin American nations, such as Ecuador and Brazil, in addition to South Asia.” 

Más